Amgen’s cancer-drug pipeline looks promising despite FDA setback, analysts say
October 11, 2023 at 08:47 AM EDT
Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|